Amanda Fisher
About Amanda Fisher
Amanda Fisher serves as the Director of Quality Control at Tessera Therapeutics, having previously held various quality control roles at bluebird bio and Repertoire Immune Medicines. She has a strong academic background in Molecular Biology, Genetics, and Biochemistry, holding a Master of Science from the University of Delaware.
Current Role at Tessera Therapeutics
Amanda Fisher serves as the Director of Quality Control at Tessera Therapeutics, a position she has held since 2024. In this role, she oversees quality control processes and ensures compliance with industry standards. Her current work is based in Somerville, Massachusetts.
Previous Experience at Repertoire Immune Medicines
Before joining Tessera Therapeutics, Amanda Fisher worked at Repertoire Immune Medicines as the Associate Director of Quality Control from 2021 to 2023. During her tenure, she contributed to the development and implementation of quality control protocols in Cambridge, Massachusetts.
Career at bluebird bio
Amanda Fisher has extensive experience at bluebird bio, where she held multiple roles. She served as QC Lead for Method Validation from 2019 to 2020, and as QC Manager from 2020 to 2021. Additionally, she worked as Associate Director for six months in 2021 and held positions as Sr. QC Analyst I and II in Method Validation and Transfer.
Educational Background
Amanda Fisher earned her Master of Science (M.S.) in Molecular Biology, Genetics, and Biochemistry from the University of Delaware, where she studied from 2011 to 2014. She also holds a Bachelor of Science (BS) in Forensic Biology from Delaware State University, completed from 2006 to 2010.
Research Experience
Prior to her industry roles, Amanda Fisher gained research experience as a Graduate Student Researcher at the University of Delaware from 2012 to 2014. She also worked as a Research Associate at Nemours from 2010 to 2012, where she contributed to various research projects in Wilmington, Delaware.